Pharmaceutical Mergers Considered

03/28/2009 05:12 am ET | Updated May 25, 2011

Sports fans have fantasy baseball. Drug industry analysts have fantasy mergers.

In the pharmaceutical version of the game, analysts use balance sheets to project how big-league drug companies could acquire more nimble rivals. The goal is to enhance product rosters, while reducing costs by shedding redundant staff and operations.

Read more on New York Times

Suggest a correction